ReviewCurrent opinion in ophthalmology2026
Advances in cataract surgery: is a new era on the horizon?
Review in Current opinion in ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bridging Preclinical and Clinical Gaps in Ocular Therapeutics: Hydrogel Drug Delivery and 3D Tissue Models.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewTo summarize recent technological, procedural and material advances that are reshaping cataract surgery and to appraise their implications for visual outcomes, safety and global accessibility. RECENT
findingsPhacoemulsification remains the gold-standard technique, yet refinements in fluidics, ultrasound modulation and heads-up 3-D visualization continue to enhance efficiency and surgeon ergonomics. Femtosecond laser assistance yields measurable benefits in dense or unstable lenses but offers comparable long-term vision to modern phaco in routine cases. Presbyopia-correcting optics have diversified: trifocal and extended-depth-of-focus lenses deliver high rates of spectacle independence, light-adjustable lenses permit postoperative power customization, and early fluid-based or dual-optic accommodative models show 2-2.5 D of true accommodation. Intraoperative tool, digital overlays, aberrometry, microscope-integrated optical coherence tomography, and artificial intelligence-driven video analytics increase refractive precision and aid training. Drug-eluting and nanopatterned intraocular lenses, portable low-cost equipment and sustainability initiatives address comorbidity management, access and environmental impact. SUMMARY: Cataract surgery is evolving into a comprehensive, personalized ocular-rehabilitation procedure that corrects refractive error, treats coexisting disease and maximizes visual quality. Parallel efforts to expand workforce capacity, reduce costs and minimize waste are essential to ensure these innovations benefit patients worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.